Although there are some experimental skin patches where GLP-1 agonist medicines like semaglutide are used as active ingredients, these are still under trial and not yet approved for use
People who combine GLP-1 medications with other weight management compounds should be especially careful about frequency and timing
It can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, abdominal discomfort, and reflux
Most chronic diseases are inflammatory in nature, and the systemic anti-inflammatory properties of GLP-1, combined with the abundance of GLP-1 receptors throughout the body, open the door to addressing cardiovascular disease, kidney disease, sleep apnea, osteoarthritis, and more, making the wider potential for this range of therapeutics very exciting
With this particular version of Kybella, Dr